PUBLISHER: Global Market Insights Inc. | PRODUCT CODE: 1516375
PUBLISHER: Global Market Insights Inc. | PRODUCT CODE: 1516375
Endoscopic Stricture Management Device Market size is projected to grow at 5.8% CAGR between 2024 and 2032. The rising prevalence of gastrointestinal disorders, such as Crohn's disease and esophageal strictures, is necessitating several effective treatment solutions. According to data from the National Library of Medicine, more than 7 million people in Europe and the U.S. will be suffering from inflammatory bowel diseases (IBD) by 2030. Significant advancements in endoscopy are enhancing the precision, efficacy, and safety of stricture management, leading to increasing adoption rates.
The growing awareness and early diagnosis of gastrointestinal conditions is also spurring the demand for these devices. The aging global population, which is more prone to such disorders is also increasing the product deployment. Minimally invasive procedures offered by these devices to reduce recovery times and improve patient outcomes is also making them a preferred choice. The favorable regulatory approvals, increasing healthcare expenditure, and reimbursement policies are further driving the market growth.
The overall market is segregated into product, application, end-user, and region.
Based on product, the endoscopic stricture management device market from the balloon dilators segment will grow at notable pace between 2024 and 2032, on account of their effectiveness in treating strictures with minimal invasiveness. These devices offer precise dilation of narrowed areas in the gastrointestinal tract while reducing the need for surgery and enhancing patient recovery. Rapid advancements are improving their safety and efficacy. The increasing prevalence of gastrointestinal disorders and the rising awareness among healthcare professionals about advanced treatment options are fueling the product demand.
Endoscopic stricture management device industry from the colonic application segment is estimated to grow at significant rate up to 2032, led by the rising incidence of colorectal diseases, such as Crohn's disease and colorectal cancer. The increasing awareness and early diagnosis are driving the demand for effective treatment options. Technological developments in endoscopic devices are improving precision and patient outcomes. The rising preference for minimally invasive procedures and the growing aging population will further boost the segment growth.
Regionally, the Asia Pacific endoscopic stricture management device market will showcase strong gains between 2024 and 2032, driven by the rising prevalence of gastrointestinal disorders, increasing healthcare expenditure, and expanding access to advanced medical technologies. The growing awareness and early diagnosis of gastrointestinal conditions is boosting the demand for these devices in the region. The aging population and the increasing adoption of minimally invasive procedures will also push the regional industry progression.